HYPERTENSION, PULMONARY
Clinical trials for HYPERTENSION, PULMONARY explained in plain language.
Never miss a new study
Get alerted when new HYPERTENSION, PULMONARY trials appear
Sign up with your email to follow new studies for HYPERTENSION, PULMONARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope to slow deadly lung disease progression
Disease control CompletedThis study tested whether adding a new drug called ralinepag to standard treatments could help people with pulmonary arterial hypertension (PAH), a serious lung and heart condition. It involved 687 adults with PAH who were already on stable medication. The main goal was to see if…
Matched conditions: HYPERTENSION, PULMONARY
Phase: PHASE3 • Sponsor: United Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Patients continue PAH drug to monitor long-term safety
Disease control CompletedThis study allowed patients with pulmonary arterial hypertension (PAH) who had previously taken riociguat in Bayer clinical trials to continue receiving the medication long-term. The main goal was to monitor the drug's safety and side effects over an extended period. Only 18 pati…
Matched conditions: HYPERTENSION, PULMONARY
Phase: PHASE4 • Sponsor: Bayer • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC
-
New blood test could catch deadly lung pressure disease sooner
Diagnosis CompletedThis study aimed to find a new way to detect pulmonary hypertension (PH) earlier using a simple blood test. Researchers analyzed blood samples from 907 people to look for tiny genetic markers (called miRNAs) that might signal the disease. They compared the accuracy of this potent…
Matched conditions: HYPERTENSION, PULMONARY
Phase: EARLY_PHASE1 • Sponsor: Janssen Research & Development, LLC • Aim: Diagnosis
Last updated Apr 01, 2026 14:42 UTC